Inactive Instrument

Calendar NeoStem Inc Nasdaq

Equities

US6406504042

End-of-day quote Nasdaq Other stock markets
- ^USD	-

23/04	Lisata Therapeutics, Qilu Pharmaceutical Dose First Patient in China Trial of LSTA1 Plus Chemo for Pancreatic Cancer	MT
23/04	Lisata Therapeutics, Inc and Qilu Pharmaceutical Co., Ltd Announce First Patient Treated in Qilu?s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma	CI

Chart calendar NeoStem Inc

df7ac2e04b749aa8e76eac0114f2519.Pk6J0VBp0DXnUp1Grp5MlrKKEtcb5Vg5gq-RqYv2jHI.SBvntWBEvk2mJ8Rx79UE5_69doJ2rDVy2MHTn-6Dwjx9ecS0HCqTZ4EQpQ~a24ff0f1d74a5d6fc8f2bbfa53a7b040

Upcoming events on NeoStem Inc

07/05/2024	Q1 2024 Earnings Release (Projected)
12/08/2024	Q2 2024 Earnings Release (Projected)
07/11/2024	Q3 2024 Earnings Release (Projected)
27/03/2025	Q4 2024 Earnings Release (Projected)

Past events on NeoStem Inc

23/04/2024 09:00 pm	Immuno Oncology Europe Summit
17/04/2024 11:00 pm	Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
10/04/2024 09:30 pm	FORCE Family Office Healthcare Conference
09/04/2024 07:30 pm	LD Micro Invitational Conference
07/03/2024 09:00 pm	OTC Markets Life Science Investor Forum
01/03/2024 03:00 am	Q4 2023 Earnings Call
01/03/2024 02:35 am	Q4 2023 Earnings Release
26/02/2024 09:45 pm	BIO CEO & Investor Conference
24/01/2024 07:30 pm	Sequire Investor Summit
17/01/2024	FORCE Family Office Healthcare Conference
04/12/2023 08:30 pm	Noble Capital Markets Emerging Growth Equity Conference
30/11/2023 07:30 am	GCFF Healthcare Investment Conference
14/11/2023	Jefferies London Healthcare Conference
13/11/2023 08:00 pm	LSX Inv€$tival Showcase
09/11/2023 10:30 am	FORCE Family Office Healthcare Conference
03/11/2023 02:00 am	Q3 2023 Earnings Call
03/11/2023 01:35 am	Q3 2023 Earnings Release
05/10/2023 07:30 pm	Bio Future Conference
03/10/2023 07:45 pm	Bio Century BayHelix East West Biopharma Summit
27/09/2023 05:45 pm	InfoSec World Conference

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	-19,1 -19,3 1.13%	-29,0 -30,4 4.62%	-57,5 -59,3 2.98%	-25,5 -27,6 7.54%	-28,8
EBIT Million USD	Released Forecast Spread	-20,1 -19,7 -1.99%	-19,1 -18,4 -3.8%	-29,1 -30,5 4.7%	-57,6 -43,7 -31.75%	-25,7 -27,2 5.34%	-28,2
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-19,4 -19,0 -1.9%	-19,0 -18,3 -4.04%	-29,0 -30,4 4.68%	-56,7 -58,8 3.56%	-23,2 -24,7 6.33%	-25,9
Net income Million USD	Released Forecast Spread	-19,4 -18,9 -2.44%	-8,15 -12,9 36.7%	-27,5 -29,6 7.34%	-54,2 -56,3 3.69%	-20,8 -23,6 11.65%	-25,9
EPS USD	Released Forecast Spread	-28,2 -27,4 -2.73%	-7,95 -12,2 34.97%	-7,50 -8,25 9.09%	-10,5 -10,9 3.86%	-2,58 -2,91 11.34%	-3,08
Announcement Date		05/03/20	25/02/21	22/03/22	30/03/23	29/02/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00	0,00
EBITDA Million USD	Released Forecast Spread	-6,84 -8,20 16.57%	-6,61 -7,00 5.53%	-6,71 -7,60 11.67%	-7,32 -7,10 -3.08%	-6,49 -8,30 21.76%	-6,80 -6,60 -2.97%	-6,83 -7,10 3.83%	-5,92 -7,90 25.1%	-5,98 -8,00 25.28%	-6,40	-6,80	-7,20	-8,40
EBIT Million USD	Released Forecast Spread	-6,85 -8,36 18.09%	-6,62 -7,19 7.94%	-6,72 -6,85 1.91%	-7,33 -6,95 -5.39%	-6,54 -7,47 12.48%		-6,88 -7,17 4.05%	-5,96 -7,89 24.42%	-6,03 -7,52 19.85%	-6,91	-6,91	-6,91	-6,91
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-6,79 -8,21 17.21%	-6,71 -7,08 5.24%	-6,63 -7,19 7.9%	-37,4 -6,98 -435.61%	-5,99 -8,10 26.04%	-6,19 -6,60 6.26%	-6,36 -6,79 6.38%	-5,26 -7,57 30.46%	-5,37 -7,02 23.59%	-6,06	-6,26	-6,46	-7,11
Net income Million USD	Released Forecast Spread	-6,79 -8,96 24.14%	-4,23 -7,08 40.28%	-6,63 -7,19 7.9%	-37,4 -6,98 -435.61%	-5,99 -8,10 26.04%	-6,19 -6,60 6.26%	-4,03 -5,69 29.23%	-5,26 -7,57 30.46%	-5,37 -7,02 23.59%	-6,06	-6,26	-6,46	-7,11
EPS USD	Released Forecast Spread	-1,65 -2,25 26.67%	-1,05 -1,73 39.13%	-1,65 -1,73 4.35%	-7,88 -1,28 -518.04%	-0,76 -1,02 25.49%	-0,77 -0,81 4.94%	-0,50 -0,70 28.57%	-0,65 -0,93 30.11%	-0,66 -0,86 22.81%	-0,73	-0,75	-0,77	-0,84
Announcement Date		22/03/22	05/05/22	04/08/22	10/11/22	30/03/23	09/05/23	14/08/23	02/11/23	29/02/24	-	-	-	-

Upcoming sector events for NeoStem Inc

06/05/2024	REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024	SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
07/05/2024	VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	PHARVARIS N.V.: Q1 2024 Earnings Release (Projected)
07/05/2024	IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	AMICUS THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)

More events

Past sector events for NeoStem Inc

Today 05:30 pm	ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 04:30 pm	BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release
Today 04:30 pm	KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today 04:30 pm	IQVIA HOLDINGS INC.: Q1 2024 Earnings Release
Today 04:00 pm	MODERNA, INC.: Q1 2024 Earnings Release
Today	VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
Today	CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today	MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
Today	RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today	INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)